Ушбу иш иқтибос қилган ишлар

261 та иш

Иш: Checkpoint inhibition and beyond: Precision immune engineering for the immune-privileged landscape of ocular malignancies

Targeting the proliferation of glioblastoma cells and enhancement of doxorubicin and temozolomide cytotoxicity through inhibition of PFKFB4 and HMOX1 genes with siRNAs
Hamzeh J. Al‐Ameer, Malek Zihlif, Ahmed O. Maslat +13
Мақола202510 иқтибос
ABI
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi, Steven O’Day, David F. McDermott +26
Мақола20109 иқтибос
ABI
Development of a candidate mRNA vaccine based on Multi-Peptide targeting VP4 of rotavirus A: an immunoinformatics and molecular dynamics approach
Cena Aram, Leila Karami, Mohammad Mehdi Ranjbar
Мақола20255 иқтибос
ABI
Convergence of evolving artificial intelligence and machine learning techniques in precision oncology
Elena Fountzilas, Tillman Pearce, Mehmet A. Baysal +2
Мақола20254 иқтибос
ABI
CAR-T cell therapy for cancer: current challenges and future directions
Inés Zugasti, Lady Espinosa-Aroca, Klaudyna Fidyt +7
Шарҳ мақола20254 иқтибос
ABI
Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy
Saber İmani, Xiaoyan Li, Xiaoyan Li +7
Шарҳ мақола20253 иқтибос
ABI
The Basic Principles of Chimeric Antigen Receptor Design
Michel Sadelain, Renier J. Brentjens, Isabelle Rivière
Шарҳ мақола20133 иқтибос
ABI
Engineering and Design of Chimeric Antigen Receptors
Sònia Guedan, Hugo Calderón, Avery D. Posey +1
Шарҳ мақола20183 иқтибос
ABI
Gene regulation by non-Coding RNAs in infertility: a mechanistic review
AmirHossien Borji, Cena Aram, Fatemeh Ziyadloo +6
Мақола20253 иқтибос
ABI
Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress
Ta‐Chiang Liu, Evanthia Galanis, David H. Kirn
Шарҳ мақола20072 иқтибос
ABI
Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer
Evanthia Galanis, Lynn C. Hartmann, William A. Cliby +17
Мақола20102 иқтибос
ABI
T cell exclusion, immune privilege, and the tumor microenvironment
Johanna A. Joyce, Douglas T. Fearon
Шарҳ мақола20152 иқтибос
ABI
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
Caroline Robert, Georgina V. Long, Benjamin Brady +25
Мақола20142 иқтибос
ABI
The Microbiome-Immune Axis Therapeutic Effects in Cancer Treatments
Young Min Son, Jihwan Kim
Шарҳ мақола20222 иқтибос
ABI
Granger Causal Inference from Spiking Observations via Latent Variable Modeling
Sahar Khosravi, Anuththara Rupasinghe, Behtash Babadi
Мақола20222 иқтибос
ABI
Patchy harmonic functional connectivity of the mouse auditory cortex
Peter Jendrichovsky, saeed Khosravi, Anuththara Rupasinghe +4
Мақола20252 иқтибос
ABI
Development of new therapeutic options for the treatment of uveal melanoma
Janney Z. Wang, Vivian Lin, Elsa Toumi +8
Шарҳ мақола20212 иқтибос
ABI
Unveiling the translational and therapeutic potential of small interfering RNA molecules in combating SARS-CoV-2: A review
Cena Aram, Faezeh Firuzpour, Maryam Barancheshmeh +1
Шарҳ мақола20252 иқтибос
ABI
HER2 CAR-T Cells Eradicate Uveal Melanoma and T-cell Therapy–Resistant Human Melanoma in IL2 Transgenic NOD/SCID IL2 Receptor Knockout Mice
Elin M.V. Forsberg, Mattias F. Lindberg, Henrik Jespersen +8
Мақола20192 иқтибос
ABI
Editorial: Advancements in multi-omics and bioinformatics for the management of solid malignancies
Noha Mousaad Elemam, Pengpeng Zhang, Wantao Wu +3
Таҳририят мақоласи20252 иқтибос
ABI
The Natural Cytotoxicity Receptors in Health and Disease
Alexander D. Barrow, Claudia Martín, Marco Colonna
Шарҳ мақола20192 иқтибос
ABI
The role of artificial intelligence in enhancing breast cancer screening and diagnosis: A review of current advances
Faezeh Firuzpour, Mohammad Heydari, Cena Aram +1
Мақола20252 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI